Your browser doesn't support javascript.
loading
Comparison of biosimilar filgrastim, originator filgrastim, and lenograstim for autologous stem cell mobilization in patients with multiple myeloma.
Lisenko, Katharina; Baertsch, Marc-Andrea; Meiser, Renate; Pavel, Petra; Bruckner, Thomas; Kriegsmann, Mark; Schmitt, Anita; Witzens-Harig, Mathias; Ho, Anthony D; Hillengass, Jens; Wuchter, Patrick.
Afiliación
  • Lisenko K; Department of Medicine V, Heidelberg University, Heidelberg, Germany.
  • Baertsch MA; Department of Medicine V, Heidelberg University, Heidelberg, Germany.
  • Meiser R; Department of Medicine V, Heidelberg University, Heidelberg, Germany.
  • Pavel P; Stem Cell Laboratory, IKTZ Heidelberg GmbH, Heidelberg, Germany.
  • Bruckner T; Institute of Medical Biometry and Informatics, Heidelberg University, Heidelberg, Germany.
  • Kriegsmann M; Institute of Pathology, Heidelberg University, Heidelberg, Germany.
  • Schmitt A; Department of Medicine V, Heidelberg University, Heidelberg, Germany.
  • Witzens-Harig M; Department of Medicine V, Heidelberg University, Heidelberg, Germany.
  • Ho AD; Department of Medicine V, Heidelberg University, Heidelberg, Germany.
  • Hillengass J; Department of Medicine V, Heidelberg University, Heidelberg, Germany.
  • Wuchter P; Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, German Red Cross Blood Service Baden-Württemberg-Hessen, Mannheim, Germany.
Transfusion ; 57(10): 2359-2365, 2017 10.
Article en En | MEDLINE | ID: mdl-28653421

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Movilización de Célula Madre Hematopoyética / Biosimilares Farmacéuticos / Mieloma Múltiple Tipo de estudio: Observational_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Transfusion Año: 2017 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Movilización de Célula Madre Hematopoyética / Biosimilares Farmacéuticos / Mieloma Múltiple Tipo de estudio: Observational_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Transfusion Año: 2017 Tipo del documento: Article País de afiliación: Alemania